美國
US 12,697,367 B2
Medicament for improving or preventing symptoms relating to retina and/or light reception and method for screening for substance capable of improving or preventing symptoms relating to retina and/or light reception
US 12,697,367 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-04。申請人：Osaka University。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- Osaka University
- 發明人
- Takahisa Furukawa; Taro Chaya
- 公開日
- 2026-08-04
- 申請日
- 2021-04-02
- 文件種類
- B2 核准公告
- 也寫作
- US 12,697,367 B2 · US12697367 · 12697367
摘要
The present invention provides a medicament for improving or preventing a symptom relating to a retina and/or light reception, the medicament comprising, as an active ingredient, a substance capable of maintaining or enhancing the phosphorylation state of Unc119; a method for screening for a substance capable of improving or preventing a symptom relating to a retina and/or light reception, the method comprising the step of selecting a substance capable of inhibiting calcineurin, or selecting a substance capable of activating casein kinase 2; and an agent for inhibiting retinal degeneration and…
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）